La Manna, Federico

Publications

Sort by

Co-Author Network

selected publications

Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer. The EMBO journal. 2024 Academic Article GET IT
Times cited: 4
Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union. Gene. 2023 Academic Article GET IT
Times cited: 2
Bladder cancer organoids as a functional system to model different disease stages and therapy response. Nature communications. 2023 Academic Article GET IT
Times cited: 29
A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection. Communications biology. 2022 Academic Article GET IT
Times cited: 1
A Model for Network-Based Identification and Pharmacological Targeting of Aberrant, Replication-Permissive Transcriptional Programs Induced by Viral Infection. 2022 GET IT
Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer. Cancer letters. 2022 Review GET IT
Times cited: 62
Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture. Molecular oncology. 2021 Academic Article GET IT
Times cited: 13
Patient-derived xenografts and organoids model therapy response in prostate cancer. Nature communications. 2021 Academic Article GET IT
Times cited: 89
Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. 2021 GET IT
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. Frontiers in oncology. 2020 Academic Article GET IT
Times cited: 27
A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles. Cancers. 2020 Review GET IT
Times cited: 12
A biomimetic 3D model of hypoxia-driven cancer progression. Scientific reports. 2019 Academic Article GET IT
Times cited: 55
Erratum: Metastases in Prostate Cancer. 2018 GET IT
Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition. International journal of molecular sciences. 2017 Academic Article GET IT
Times cited: 26
CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer. Oncogene. 2017 Academic Article GET IT
Times cited: 29
CORRECTION: Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model. 2017 GET IT
Times cited: 1
Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model. Biology open. 2017 Academic Article GET IT
Times cited: 13
Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model. International journal of molecular sciences. 2016 Academic Article GET IT
Times cited: 84
RANKL: A promising circulating marker for bone metastasis response. Oncology letters. 2016 Academic Article GET IT
Times cited: 28
Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report. 2015 GET IT
Times cited: 6
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma. OncoTargets and therapy. 2015 Academic Article GET IT
Times cited: 31
The Human Mesenchymal Stromal Cell-Derived Osteocyte Capacity to Modulate Dendritic Cell Functions Is Strictly Dependent on the Culture System. Journal of immunology research. 2015 Academic Article GET IT
Times cited: 6
Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report. 2014 GET IT
Times cited: 8
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature. OncoTargets and therapy. 2014 Academic Article GET IT
Times cited: 13
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems. Bone. 2014 Academic Article GET IT
Times cited: 29

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Beyond vicious: addressing how prostate cancer dysregulates the local stem cell compartments to promote bone metastasis Fellow: Federico La Manna awarded by American Italian Cancer Foundation Principal Investigator 2024 - 2025

more ...

less ...

Background

education and training

Ph.D., Leiden University (Netherlands) 21
M.Sc., University of Bologna (Italy) 2012
B.Sc., University of Bologna (Italy) 2009

Contact

full name

Federico La Manna

primary email

fel4001@med.cornell.edu

VIVO Weill Cornell Medical College

Federico La Manna Postdoctoral Associate in Pathology and Laboratory Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email